» Articles » PMID: 8247223

Clinical Comparison of Alzheimer's Disease in Pedigrees with the Codon 717 Val-->Ile Mutation in the Amyloid Precursor Protein Gene

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 1993 Sep 1
PMID 8247223
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is the most common cause of dementia (32). Although the majority of cases of AD are sporadic, the most consistent risk factor detected in several epidemiological studies has been a positive family history of the disease (14,21). In addition, many large pedigrees have been described in which AD appears to be inherited as an autosomal dominant disorder. In one such pedigree (F23) a point mutation within the beta-amyloid precursor protein (APP) gene at codon 717 was identified and hypothesized to be pathogenic (10). The mutation results in a valine to isoleucine change in APP (APP717 Val-->Ile). Subsequent screening has revealed four other pedigrees, detailed in this study, in which this mutation co-segregates with AD (13,26,37). In addition, one other pedigree (Tor3) with this mutation has been described (15) and detailed clinical, neuropsychological, and neuropathological data are reported. Tor3 is discussed below in comparison to the findings in the families in this study. The five families we report with the mutation were identified in Britain (1 family), the United States (1 family), and Japan (3 families). The mutation has not been reported in the general population of any of these countries (3,13,26,33). On this basis alone it seems this mutation is pathogenic. Other APP codon 717 mutations have been identified which co-segregate with the disease (4,25). Also, a double mutation in APP at codons 670/671 has been shown to cosegregate with the disease in two large Swedish pedigrees (22). In all cases, there is complete co-segregation of the APP mutation with early onset AD, providing overwhelming statistical evidence that these mutations are pathogenic. We present the clinical features and limited neuropathology of AD in these families with the APP 717 Val-->Ile mutation.

Citing Articles

The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the mutation: Randomized data simulation.

Zuno-Reyes A, Perez-Rubio K, Flores-Gonzalez M, Torres R, Dumois-Petersen S, Figuera L Alzheimers Dement (Amst). 2024; 16(3):e12631.

PMID: 39170093 PMC: 11336201. DOI: 10.1002/dad2.12631.


Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches.

Firdaus Z, Li X Int J Mol Sci. 2024; 25(4).

PMID: 38396996 PMC: 10889342. DOI: 10.3390/ijms25042320.


Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer's disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations.

Liu Y, Xiao X, Liu H, Liao X, Zhou Y, Weng L Front Aging Neurosci. 2022; 14:1013295.

PMID: 36313020 PMC: 9616047. DOI: 10.3389/fnagi.2022.1013295.


Abnormal retinal capillary blood flow in autosomal dominant Alzheimer's disease.

Singer M, Ringman J, Chu Z, Zhou X, Jiang X, Shahidzadeh A Alzheimers Dement (Amst). 2021; 13(1):e12162.

PMID: 33728371 PMC: 7931411. DOI: 10.1002/dad2.12162.


Genetic Insights into Alzheimer's Disease.

Latimer C, Lucot K, Keene C, Cholerton B, Montine T Annu Rev Pathol. 2021; 16:351-376.

PMID: 33497263 PMC: 8664069. DOI: 10.1146/annurev-pathmechdis-012419-032551.